December 2007- Volume 3, Issue 12
December 2007
In this Issue
Genomics & Proteomics
RXi and Invitrogen: All quiet on the RNAi front
RXi and Invitrogen: All quiet on the RNAi front
RXi Pharmaceutical and Invitrogen announced they have entered into an agreement for RXi to license on an exclusive basis second-generation RNAi technology from Invitrogen for designated target genes in all human therapeutic categories.
On your mark, get set...
On your mark, get set...
NextGen appoints new CEO and expands services into protein biomarker monitoring
Band-aid for the brain?
Band-aid for the brain?
Alzheimer’s drugs target symptoms not disease
Global News
Allies against Alzheimer’s
Allies against Alzheimer’s
Biogen Idec and Neurimmune to work on antibody-based treatment for AD
GPC begins restructuring
GPC begins restructuring
Staff reductions of approximately 44 percent are in store for GPC Biotech AG after the recent announcement of a corporate restructuring plan
All that glitters
All that glitters
Nanoengineers mine tiny diamonds for drug delivery
Research & Development
Gene Logic discovers new use for Pfizer drug
Gene Logic discovers new use for Pfizer drug
Gene Logic Inc. recently announced a collaboration milestone, triggered by the filing of a patent application for a new use of an existing Pfizer drug candidate to treat solid tumors
Rosetta and NYU expand microRNA collaboration
Rosetta and NYU expand microRNA collaboration
Israel-Rosetta Genomics Ltd. and the New York University School of Medicine have expanded their collaboration to include congenital heart disease.
SRI vs. HIV
SRI vs. HIV
SRI in new contract with NIAID for preclinical services
Antisense approach to scars
Antisense approach to scars
Isis and Excaliard look to topical antisense drugs to treat scars and other fibrotic conditions
Putting on a new spin
Putting on a new spin
Amgen spins out Relypsa from newly acquired Ilypsa
Automation & Instrumentation
Xceed launches Strategic Collaborator program
Xceed launches Strategic Collaborator program
Xceed has already committed to several other institutions under its Strategic Collaborator program
WaferGen’s alpha dog
WaferGen’s alpha dog
Pitt Med School tapped as alpha test site for WaferGen’s real-time PCR system
One molecule at a time
One molecule at a time
Team-up of Agilent and BioNanomatrix focuses on nanoscale whole-genome imaging and analysis
Informatics
Schizophrenia data deal
Schizophrenia data deal
Genizon Biosciences and NDEI to share samples, technology
Free for all (students)
Free for all (students)
Accelrys makes SciTegic Pipeline Pilot Student Edition free to academic researchers
